16.28
0.08 (0.49%)
| Previous Close | 16.20 |
| Open | 16.18 |
| Volume | 230,171 |
| Avg. Volume (3M) | 1,402,696 |
| Market Cap | 4,624,285,696 |
| Price / Earnings (TTM) | 180.89 |
| Price / Earnings (Forward) | 20.20 |
| Price / Sales | 4.11 |
| Price / Book | 9.02 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | 2.24% |
| Operating Margin (TTM) | 27.86% |
| Diluted EPS (TTM) | 0.090 |
| Quarterly Revenue Growth (YOY) | 2.60% |
| Quarterly Earnings Growth (YOY) | -68.10% |
| Total Debt/Equity (MRQ) | 566.88% |
| Current Ratio (MRQ) | 2.46 |
| Operating Cash Flow (TTM) | 269.99 M |
| Levered Free Cash Flow (TTM) | 194.97 M |
| Return on Assets (TTM) | 7.01% |
| Return on Equity (TTM) | 5.88% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Mixed |
| Diagnostics & Research (Global) | Mixed | Mixed | |
| Stock | Sotera Health Company | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -3.5 |
| Insider Activity | -3.0 |
| Price Volatility | -4.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 4.0 |
| Average | -1.10 |
|
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Small Core |
| % Held by Insiders | 2.51% |
| % Held by Institutions | 95.98% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Warburg Pincus Llc | 30 Jun 2025 | 73,822,952 |
| Gtcr Llc | 30 Jun 2025 | 49,215,301 |
| 52 Weeks Range | ||
| Median | 13.00 (-20.15%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 24 Jun 2025 | 13.00 (-20.15%) | Buy | 11.24 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| GTCR INVESTMENT XI LLC | - | 15.62 | -8,000,000 | -124,960,000 |
| WARBURG PINCUS & CO. | - | 15.62 | -12,000,000 | -187,440,000 |
| Aggregate Net Quantity | -20,000,000 | |||
| Aggregate Net Value ($) | -312,400,000 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 15.62 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GTCR INVESTMENT XI LLC | Director | 05 Sep 2025 | Sell (-) | 8,000,000 | 15.62 | 124,960,000 |
| WARBURG PINCUS & CO. | Director | 05 Sep 2025 | Sell (-) | 12,000,000 | 15.62 | 187,440,000 |
| Date | Type | Details |
|---|---|---|
| 03 Sep 2025 | Announcement | Sotera Health Announces Secondary Offering of Common Stock |
| 08 Aug 2025 | Announcement | Sotera Health Reports Strong Second-Quarter and First-Half 2025 Results |
| 28 Jul 2025 | Announcement | Sotera Health Announces Second-Quarter 2025 Earnings Release Date |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |